Norcyclobenzaprine D3 | CAS 1784779-86-7 - Request Quote
Norcyclobenzaprine D3
| SZ CAT No: | SZ-C047D02 |
| CAS No | 1784779-86-7 |
| Mol.F. | C19H16D3N |
| Mol.Wt. | 264.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Norcyclobenzaprine D3 is chemically 3-(5H-Dibenzo[a,d][7]annulen-5-ylidene)-N-(methyl-d3)propan-1-amine. Norcyclobenzaprine D3 is supplied with detailed characterization data compliant with regulatory guideline. Norcyclobenzaprine D3 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Cyclobenzaprine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1784779-86-7
Purchase 1784779-86-7
Order 1784779-86-7
Enquire 1784779-86-7
price of 1784779-86-7
1784779-86-7 Supplier
1784779-86-7 Manufacturer
1784779-86-7 Exporter
buy high quality Norcyclobenzaprine D3
Purchase Norcyclobenzaprine D3
Norcyclobenzaprine D3 suppliers
Norcyclobenzaprine D3 manufacturers
Norcyclobenzaprine D3 price
Order Norcyclobenzaprine D3
Enquire Norcyclobenzaprine D3
Norcyclobenzaprine D3 cost
Norcyclobenzaprine D3 Supplier
Norcyclobenzaprine D3 Distributor
Norcyclobenzaprine D3 for Method Validation
Cyclobenzaprine Reference Standard
Norcyclobenzaprine D3 for ANDA Filing
Norcyclobenzaprine D3 for Forced Degradation Studies
Norcyclobenzaprine D3 Identification Standards
Norcyclobenzaprine D3 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


